0 Comments
0 Shares
459 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Precision Oncology Drugs: The Evolving NRG1 Fusion Market for Targeted Cancer TherapeuticsThe field of precision oncology has advanced significantly, with targeted therapies offering new treatment options for patients with genetically defined cancers. Among the most promising targets are rare gene fusions, including NRG1 fusions, which are found in a small but significant subset of solid tumors. The precision oncology drugs market is experiencing substantial growth, with...0 Comments 0 Shares 534 Views 0 Reviews
-
AI In Genomics Market and the Expansion of Precision OncologyThe global AI in genomics market was valued at USD 1.3 billion in 2025 and is projected to reach USD 18.8 billion by 2033, expanding from USD 1.7 billion in 2026 at a 40.3% CAGR from 2026 to 2033. North America represented the leading regional market, accounting for 38.36% of global revenue in 2025. Market expansion is being driven by the rapid...0 Comments 0 Shares 185 Views 0 Reviews
-
Anti-Neoplastic Agents Market to Expand Through 2034 With Growing Focus on Precision OncologyAnti-Neoplastic Agents Market Analysis indicates that market expansion is being supported by the evolution of personalized medicine, targeted cancer treatments, increasing awareness, and technological advancements across drug discovery and development. The report evaluates market performance across major regions, including North America, Europe, Asia-Pacific, South and Central America, and the...0 Comments 0 Shares 160 Views 0 Reviews
-
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Targeted Oncology Therapies, Precision Medicine for Lung and Colorectal Cancer"Future of Executive Summary Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2021 to 2028 and is expected to reach 358.26 million by 2028. The Asia-Pacific Kirsten Rat Sarcoma (KRAS) report encompasses the key developments in the market with respect to the...0 Comments 0 Shares 1K Views 0 Reviews
-
Biomarker Technologies in Precision Medicine and Oncology: Global Market Dynamics & Opportunity Assessment, 2026–2033According to the latest report published by Data Bridge Market Research, the Biomarker Technologies Market The global biomarker technologies market size was valued at USD 48.02 billion in 2024 and is expected to reach USD 139.40 billion by 2032, at a CAGR of 14.25% during the forecast period With the clear understanding of customer requirement, one method or combination of many...0 Comments 0 Shares 295 Views 0 Reviews
-
Brain Tumor Diagnosis Treatments Market - Advanced Imaging Precision Transforming Neuro-Oncology CareMarket Overview The brain tumor diagnosis treatments market is transforming as advanced imaging precision reshapes neuro-oncology care pathways. The Brain Tumor Diagnosis Treatments Market is projected to grow through 2030, driven by rising brain tumor incidence rates, growing adoption of advanced imaging modalities, expanding minimally invasive surgical techniques, and increasing integration...0 Comments 0 Shares 357 Views 0 Reviews
-
Breast Cancer Immunotherapy Market – Precision Immune Approaches Reshaping Oncology CareMarket Overview The breast cancer immunotherapy market is expanding rapidly as checkpoint inhibitors, antibody-drug conjugates, and emerging cellular therapies move beyond triple-negative subtypes into broader clinical use. Oncologists increasingly incorporate immune-based approaches alongside chemotherapy and targeted agents, reflecting a shift toward personalized treatment strategies guided...0 Comments 0 Shares 146 Views 0 Reviews
-
Circulating Tumor Cells Cancer Stem Cells Market – Liquid Biopsy Innovation Advancing Precision OncologyMarket Overview The circulating tumor cells cancer stem cells market is expanding as liquid biopsy technology gains traction for non-invasive cancer detection, monitoring, and treatment response assessment. By isolating and analyzing rare tumor cells circulating in a patient's bloodstream, clinicians can gather valuable information about cancer progression without invasive tissue biopsies....0 Comments 0 Shares 63 Views 0 Reviews
-
Cyclin Dependent Kinase Inhibitor Market – Precision Oncology Advancing Through Targeted Cell Cycle TherapyMarket Overview The cyclin dependent kinase inhibitor market is expanding rapidly as oncology shifts toward precision therapies that halt uncontrolled cell division at its source. These inhibitors block specific enzymes responsible for driving the cell cycle in cancer cells, particularly in breast cancer and other hormone-receptor-positive malignancies. Growth is fueled by rising cancer...0 Comments 0 Shares 98 Views 0 Reviews
-
Exosomes Market – Diagnostic Biomarkers Reshaping Precision OncologyMarket Overview The exosomes market is gaining significant momentum as researchers unlock the potential of extracellular vesicles for non-invasive disease detection. These nanoscale membrane-bound particles carry proteins, lipids, and nucleic acids that reflect the physiological state of their parent cells. Diagnostic companies are developing exosome-based liquid biopsy platforms that detect...0 Comments 0 Shares 183 Views 0 Reviews
-
Gene Panel Market – Powering Precision Diagnostics in Oncology and BeyondThe gene panel market sits at the core of precision diagnostics, enabling simultaneous analysis of multiple genes linked to specific diseases. It is a critical enabler of targeted therapy selection, risk assessment, and increasingly, population‑level screening strategies. The market was valued at approximately USD 6.8 billion in 2023, around USD 7.67 billion in 2024, and is projected to reach...0 Comments 0 Shares 259 Views 0 Reviews
-
The Role of Electronic Health Records in Real-World Evidence for OncologyReal-World Evidence Solutions for Oncology: How Patient Data Is Shaping Cancer Research Cancer research is becoming increasingly data-driven as researchers, healthcare providers, and regulators look beyond traditional clinical trials to understand what happens to patients in everyday healthcare settings. Real-World Evidence (RWE) Solutions for Oncology are becoming an important part of this...0 Comments 0 Shares 364 Views 0 Reviews
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Comments 0 Shares 10K Views 0 Reviews
-
Adrenal Cancer Diagnostics Market Size, Share, and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Comments 0 Shares 3K Views 0 Reviews
-
Advanced Immunohistochemistry Applications Supporting Market DevelopmentThe Tissue Diagnostics market is witnessing strong growth as healthcare systems across the world increasingly focus on early disease detection, precision medicine, and advanced cancer diagnosis. The global tissue diagnostics market size was valued at USD 9.37 billion in 2025 and is projected to reach USD 18.58 billion by 2033, growing at a CAGR of 9.11% from 2026 to 2033. The growing prevalence...0 Comments 0 Shares 1K Views 0 Reviews
-
AI in Oncology Market Finds New Growth Across Diagnostics and Clinical ResearchThe AI in oncology market is entering a rapid expansion phase as healthcare providers, researchers, and pharmaceutical companies increasingly use artificial intelligence to improve cancer diagnostics, treatment planning, and research. The market was valued at USD 6.0 billion in 2025 and is projected to grow from USD 8.3 billion in 2026 to USD 38.9 billion by 2033, registering a CAGR of 24.8%...0 Comments 0 Shares 453 Views 0 Reviews
-
Alpha Emitter Market: Tripling to $3.09 Billion by 2032ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...0 Comments 0 Shares 5K Views 0 Reviews
-
Asia-Pacific Radiotherapy Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Radiotherapy Market The Asia-Pacific radiotherapy market size was valued at USD 1.06 billion in 2024 and is expected to reach USD 2.40 billion by 2032, at a CAGR of 11.2% during the forecast period This world-wide Asia-Pacific Radiotherapy Market report is...0 Comments 0 Shares 11K Views 0 Reviews
-
Biomarker-Based Testing Gains Importance Across the Cancer Care JourneyThe cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...0 Comments 0 Shares 711 Views 0 Reviews
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Comments 0 Shares 12K Views 0 Reviews
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Comments 0 Shares 9K Views 0 Reviews
-
Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Comments 0 Shares 11K Views 0 Reviews
-
Clinical Trials Market Growth Supported by Rare Disease Research ExpansionThe clinical trials market is witnessing strong momentum as pharmaceutical and biotechnology companies continue to increase investments in research and development to accelerate the discovery of advanced therapies. The global clinical trials market size was estimated at USD 89.0 billion in 2025 and is projected to reach USD 158.4 billion by 2033, growing at a CAGR of 7.7% from 2026 to 2033. The...0 Comments 0 Shares 1K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali